Rani BR, Kumar MA, Babu KS, Rao TN. An open label randomized placebo-controlled study of apremilast in common immune mediated papulosquamous hair and pigmentary dermatoses. Int J Res Dermatol [Internet]. 2022 Feb. 24 [cited 2025 Nov. 10];8(2):254-9. Available from: https://www.ijord.com/index.php/ijord/article/view/1511